Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non‐inferiority, open‐label, clinical study (SPRITE study).

Published in:

BJU International, 2018, v. 122, n. 2, p. 317, doi. 10.1111/bju.14209

By:

• on behalf of the SPRITE investigators;
• Morgia, Giuseppe;
• Russo, Giorgio I.;
• Carrino, Maurizio;
• Giannantoni, Antonella;
• Blefari, Franco;
• Arnone, Salvatore;
• Santelli, Giorgio;
• Vespasiani, Giuseppe;
• Pareo, Rosaria M.;
• Voce, Salvatore;
• Madonia, Massimo;
• Carini, Marco;
• Ingrassia, Antonio;
• Terrone, Carlo;
• Gentile, Marcello

Publication type:

Article